Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

Martha Pavlakis, M.D.

TitleAssociate Professor of Medicine
InstitutionBeth Israel Deaconess Medical Center
DepartmentMedicine
AddressBeth Israel Deaconess Med Ctr
7th Floor
110 Francis Street
Boston MA 02215
Phone617/632-9700
Fax617/632-9804

 Bibliographic 
 selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Rodrigue JR, Paek MJ, Egbuna O, Waterman AD, Pavlakis M, Mandelbrot DA. Willingness to Pursue Live-Donor Kidney Transplantation Among Waitlisted Patients Infected With Human Immunodeficiency Virus (HIV): A Preliminary Investigation. Transplantation. 2013 Mar 27; 95(6):787-90.
    View in: PubMed
  2. Pavlakis M, Kher A. Pre-emptive Kidney Transplantation to Improve Survival in Patients With Type 1 Diabetes and Imminent Risk of ESRD. Semin Nephrol. 2012 Sep; 32(5):505-11.
    View in: PubMed
  3. Mandelbrot DA, Pavlakis M. Living donor practices in the United States. Adv Chronic Kidney Dis. 2012 Jul; 19(4):212-9.
    View in: PubMed
  4. Rodrigue JR, Pavlakis M, Egbuna O, Paek M, Waterman AD, Mandelbrot DA. The "House Calls" trial: a randomized controlled trial to reduce racial disparities in live donor kidney transplantation: rationale and design. Contemp Clin Trials. 2012 Jul; 33(4):811-8.
    View in: PubMed
  5. Francis JM, Palmer MR, Donohoe K, Curry M, Johnson SR, Karp SJ, Evenson AR, Pavlakis M, Hanto DW, Mandelbrot DA. Evaluation of native kidney recovery after simultaneous liver-kidney transplantation. Transplantation. 2012 Mar 15; 93(5):530-5.
    View in: PubMed
  6. Pavlakis M. The timing of dialysis and kidney transplantation in type 1 diabetes. Diabetes Obes Metab. 2012 Aug; 14(8):689-93.
    View in: PubMed
  7. Xu S, Williams ME, Pavlakis M, Breu AC. The UNOS 'preferential allocation' concept proposal for the allocation of deceased donor kidney transplants: implications for patients with diabetes. Nephrol Dial Transplant. 2012 Mar; 27(3):869-71.
    View in: PubMed
  8. Pavlakis M, Hanto DW. Clinical pathways in transplantation: a review and examples from Beth Israel Deaconess Medical Center. Clin Transplant. 2012 May-Jun; 26(3):382-6.
    View in: PubMed
  9. Garg J, Karim M, Tang H, Sandhu GS, DeSilva R, Rodrigue JR, Pavlakis M, Hanto DW, Baird BC, Goldfarb-Rumyantzev AS. Social adaptability index predicts kidney transplant outcome: a single-center retrospective analysis. Nephrol Dial Transplant. 2012 Mar; 27(3):1239-45.
    View in: PubMed
  10. Pavlakis M, Kumar V. Introduction to the well-transplant visit--more than vital signs and a creatinine check. Clin J Am Soc Nephrol. 2011 Jul; 6(7):1773.
    View in: PubMed
  11. Kasper EM, Bartek J, Johnson S, Kasper BS, Pavlakis M, Wong M. Post-transplant aspergillosis and the role of combined neurosurgical and antifungal therapies under belatacept immunosuppression. Surg Neurol Int. 2011; 2:75.
    View in: PubMed
  12. Rodrigue JR, Ladin K, Pavlakis M, Mandelbrot DA. Disclosing recipient information to potential living donors: preferences of donors and recipients, before and after surgery. Am J Transplant. 2011 Jun; 11(6):1270-8.
    View in: PubMed
  13. Pavlakis M. Live kidney donation: a 36-year-old woman hoping to donate a kidney to her mother. JAMA. 2011 Feb 9; 305(6):592-9.
    View in: PubMed
  14. Sandhu GS, Khattak M, Woodward RS, Hanto DW, Pavlakis M, Dimitri N, Goldfarb-Rumyantzev AS. Impact of substance abuse on access to renal transplantation. Transplantation. 2011 Jan 15; 91(1):86-93.
    View in: PubMed
  15. Rodrigue JR, Dimitri N, Reed A, Antonellis T, Pavlakis M, Johnson SR, Mandelbrot DA. Spouse caregivers of kidney transplant patients: quality of life and psychosocial outcomes. Prog Transplant. 2010 Dec; 20(4):335-42; quiz 343.
    View in: PubMed
  16. Rodrigue JR, Mandelbrot DA, Hanto DW, Johnson SR, Karp SJ, Pavlakis M. A cross-sectional study of fatigue and sleep quality before and after kidney transplantation. Clin Transplant. 2011 Jan-Feb; 25(1):E13-21.
    View in: PubMed
  17. Mawardi H, Pavlakis M, Mandelbrot D, Woo SB. Sirolimus oral ulcer with Cedecea davisae superinfection. Transpl Infect Dis. 2010 Oct; 12(5):446-50.
    View in: PubMed
  18. Rodrigue JR, Mandelbrot DA, Pavlakis M. A psychological intervention to improve quality of life and reduce psychological distress in adults awaiting kidney transplantation. Nephrol Dial Transplant. 2011 Feb; 26(2):709-15.
    View in: PubMed
  19. Pavlakis M, Khwaja K, Mandelbrot D, Tang H, Whiting JW, Lorber MI, Gautam A, Johnson SR, Uknis ME. Renal allograft failure predictors after PAK transplantation: results from the New England Collaborative Association of Pancreas Programs. Transplantation. 2010 Jun 15; 89(11):1347-53.
    View in: PubMed
  20. Bodonyi-Kovacs G, Putheti P, Marino M, Avihingsanon Y, Uknis ME, Monaco AP, Strom TB, Pavlakis M. Gene expression profiling of the donor kidney at the time of transplantation predicts clinical outcomes 2 years after transplantation. Hum Immunol. 2010 May; 71(5):451-5.
    View in: PubMed
  21. Chudzinski RE, Khwaja K, Teune P, Miller J, Tang H, Pavlakis M, Rogers C, Johnson S, Karp S, Hanto D, Mandelbrot D. Successful DCD kidney transplantation using early corticosteroid withdrawal. Am J Transplant. 2010 Jan; 10(1):115-23.
    View in: PubMed
  22. Mandelbrot DA, Pavlakis M, Karp SJ, Johnson SR, Hanto DW, Rodrigue JR. Practices and barriers in long-term living kidney donor follow-up: a survey of U.S. transplant centers. Transplantation. 2009 Oct 15; 88(7):855-60.
    View in: PubMed
  23. Stillman IE, Pavlakis M. Allograft biopsies: studying them for all they're worth. J Am Soc Nephrol. 2009 Nov; 20(11):2282-4.
    View in: PubMed
  24. Egbuna OI, Davis RB, Chudinski R, Pavlakis M, Rogers C, Molakatalla P, Johnson SR, Karp S, Monaco AP, Tang H, Hanto DW, Mandelbrot DA. Outcomes with conversion from calcineurin inhibitors to sirolimus after renal transplantation in the context of steroid withdrawal or steroid continuation. Transplantation. 2009 Sep 15; 88(5):684-92.
    View in: PubMed
  25. Rogers CC, Johnson SR, Mandelbrot DA, Pavlakis M, Horwedel T, Karp SJ, Egbuna O, Rodrigue JR, Chudzinski RE, Goldfarb-Rumyantzev AS, Hanto DW, Curry MP. Timing of sirolimus conversion influences recovery of renal function in liver transplant recipients. Clin Transplant. 2009 Nov-Dec; 23(6):887-96.
    View in: PubMed
  26. Pavlakis M. Can cardiac troponin T level be used to predict survival of patients awaiting renal transplantation? Nat Clin Pract Nephrol. 2009 Mar; 5(3):124-5.
    View in: PubMed
  27. Pavlakis M. Case presentations on two patients who received bortezomib for antibody mediated rejection at BIDMC. Clin Transpl. 2009; 343-5.
    View in: PubMed
  28. Pavlakis M, Goldfarb-Rumyantzev AS. Diabetes after transplantation and sirolimus: what's the connection? J Am Soc Nephrol. 2008 Jul; 19(7):1255-6.
    View in: PubMed
  29. Ho KJ, Owens CD, Johnson SR, Khwaja K, Curry MP, Pavlakis M, Mandelbrot D, Pomposelli JJ, Shah SA, Saidi RF, Ko DS, Malek S, Belcher J, Hull D, Tullius SG, Freeman RB, Pomfret EA, Whiting JF, Hanto DW, Karp SJ. Donor postextubation hypotension and age correlate with outcome after donation after cardiac death transplantation. Transplantation. 2008 Jun 15; 85(11):1588-94.
    View in: PubMed
  30. Rodrigue JR, Guenther R, Kaplan B, Mandelbrot DA, Pavlakis M, Howard RJ. Measuring the expectations of kidney donors: initial psychometric properties of the Living Donation Expectancies Questionnaire. Transplantation. 2008 May 15; 85(9):1230-4.
    View in: PubMed
  31. Tarkan JL, Woo SB, Pavlakis M, Johnson SR, Chirieac LR, Chimienti SN, Mandelbrot DA. Spotting the owl: surreptitious cytomegalovirus disease in a renal transplant recipient. Clin Transplant. 2008 May-Jun; 22(3):391-5.
    View in: PubMed
  32. Pavlakis M, Hanto D, Mandelbrot D. Do we know enough to mandate donor evaluation testing? Am J Transplant. 2008 Feb; 8(2):466.
    View in: PubMed
  33. Pavlakis M. Resolved: in minimizing kidney transplant immunosuppression, steroids should go before calcineurin inhibitors: con. J Am Soc Nephrol. 2007 Dec; 18(12):3028-30.
    View in: PubMed
  34. Rodrigue JR, Pavlakis M, Danovitch GM, Johnson SR, Karp SJ, Khwaja K, Hanto DW, Mandelbrot DA. Evaluating living kidney donors: relationship types, psychosocial criteria, and consent processes at US transplant programs. Am J Transplant. 2007 Oct; 7(10):2326-32.
    View in: PubMed
  35. Mandelbrot DA, Pavlakis M, Danovitch GM, Johnson SR, Karp SJ, Khwaja K, Hanto DW, Rodrigue JR. The medical evaluation of living kidney donors: a survey of US transplant centers. Am J Transplant. 2007 Oct; 7(10):2333-43.
    View in: PubMed
  36. Pavlakis, M. Resolved: In minimizing kidney transplant immunosuppression steroids should go before calcineurin inhibitors. . Journal of the American Society of Nephrology. 2007.
  37. Egbuna O, Pavlakis M, Stillman IE. Acute crescentic glomerulonephritis in a renal allograft: an unusual complication of fungal infection. Am J Kidney Dis. 2007 Sep; 50(3):468-70.
    View in: PubMed
  38. Pavlakis, M. Preemptive Transplantation: Kidney Transplantation BEFORE Starting Dialysis Frequently Asked Questions . 2007.
  39. Egbuna O, Johnson S, Pavlakis M. Rupture of an infected liver cyst into the pericardium in a kidney transplant recipient with polycystic kidney disease. Am J Kidney Dis. 2007 Jun; 49(6):851-3.
    View in: PubMed
  40. Pavlakis M, Khwaja K. Pancreas and islet cell transplantation in diabetes. Curr Opin Endocrinol Diabetes Obes. 2007 Apr; 14(2):146-50.
    View in: PubMed
  41. Armenti V, Josephson M, McKay D, Pavlakis M. Parenthood after Transplantation. 2007.
  42. Sustained donor hypotension and long times to death during dcd KIdney procurement correlate with increased rates of DGF and worse long term renal function. ASTS Winter Symposium Poster Presentation. 2007.
  43. Tuohy KA, Johnson S, Khwaja K, Pavlakis M. Gender disparities in the live kidney donor evaluation process. Transplantation. 2006 Dec 15; 82(11):1402-7.
    View in: PubMed
  44. Pavlakis M, Khwaja K. Transplantation for type 1 diabetes: whole organ pancreas and islet cells. Curr Diab Rep. 2006 Dec; 6(6):473-8.
    View in: PubMed
  45. Johnson SR, Cherikh WS, Kauffman HM, Pavlakis M, Hanto DW. Retransplantation after post-transplant lymphoproliferative disorders: an OPTN/UNOS database analysis. Am J Transplant. 2006 Nov; 6(11):2743-9.
    View in: PubMed
  46. S. R. Johnson, W. S. Cherikh, H. M. Kauffman, M. Pavlakis, D. W. Hanto. Retransplantation After Post-Transplant Lymphoproliferative Disorders: An OPTN/UNOS Database Analysis. American Journal of Transplantation. 2006; 6(11):2743.
  47. Pavlakis M. Mycophenolate mofetil versus sirolimus as an adjunct to calcineurin inhibition after renal transplantation. Nat Clin Pract Nephrol. 2006 Oct; 2(10):558-9.
    View in: PubMed
  48. McKay DB, Adams PL, Bumgardner GL, Davis CL, Fine RN, Krams SM, Martinez OM, Murphy B, Pavlakis M, Tolkoff-Rubin N, Sherman MS, Josephson MA. Reproduction and pregnancy in transplant recipients: current practices. Prog Transplant. 2006 Jun; 16(2):127-32.
    View in: PubMed
  49. Ogo Egbuna, MD; Martha Pavlakis, MD; Scott Johnson, MD; Khalid Khwaja, MD; Seth Karp, MD; Christin Rodgers, Pharm D; Michael Curry, MD; Emily Snow; Douglas Hanto, Didier Mandelbrot . Efficacy and safety of conversion from calcineurin inhibitors to sirolimus after early steroid withdrawal kidney transplantation. American Journal of Transplantation. 2006.
  50. Pavlakis M, Haririan A, Klassen DK. BK virus infection after non-renal transplantation. Adv Exp Med Biol. 2006; 577:185-9.
    View in: PubMed
  51. Johnson SR, Pavlakis M, Khwaja K, Karp SJ, Curry M, Curran CC, Monaco AP, Hanto DW. Intensive care unit extubation does not preclude extrarenal organ recovery from donors after cardiac death. Transplantation. 2005 Nov 15; 80(9):1244-50.
    View in: PubMed
  52. Martha Pavlakis, Marc E. Uknis, James W. Whiting, Mark Lorber, Amitabh Gautam, Khalid Khwaja and Scott R. Johnson. Predictors of Renal Allograft Failure after Pancreas after Kidney (PAK) Transplant . Journal of the American Society of Transplantation. 2005.
  53. Martha Pavlakis, Didier Mandelbrot, Seth Karp, Khalid Khwaja and Scott R. Johnson. BK Virus Screening and Outcomes in a Steroid Withdrawal (SW) and Steroid Continuation (SC) in Kidney Transplantation. Journal of the American Society of Nephrology. 2005.
  54. Martha Pavlakis, Kathryn Touhy, Asher Schachter, Khalid Khwaja and Scott R. Johnson. Laparoscopic Nephrectomy Eliminates the Gender Disparity in Kidney Donation . Journal of the American Society of Nephrology. 2005.
  55. Johnson SR, Khwaja K, Pavlakis M, Monaco AP, Hanto DW. Older living donors provide excellent quality kidneys: a single center experience (older living donors). Clin Transplant. 2005 Oct; 19(5):600-6.
    View in: PubMed
  56. Pavlakis M. New-onset diabetes after transplantation. Curr Diab Rep. 2005 Aug; 5(4):300-4.
    View in: PubMed
  57. McKay DB, Josephson MA, Armenti VT, August P, Coscia LA, Davis CL, Davison JM, Easterling T, Friedman JE, Hou S, Karlix J, Lake KD, Lindheimer M, Matas AJ, Moritz MJ, Riely CA, Ross LF, Scott JR, Wagoner LE, Wrenshall L, Adams PL, Bumgardner GL, Fine RN, Goral S, Krams SM, Martinez OM, Tolkoff-Rubin N, Pavlakis M, Scantlebury V. Reproduction and transplantation: report on the AST Consensus Conference on Reproductive Issues and Transplantation. Am J Transplant. 2005 Jul; 5(7):1592-9.
    View in: PubMed
  58. Primary authors:Diane McCay, Michelle Josephson Secondary authors: Vincent Armenti, Phillis August, Lisa Coscia, Connie Davis, John Davison, Thomas Easterling, Jan Friedman, Susan Jou, Janet Karlix, Kathleen Lake, Marshall Lindheimer, Arthur Matas, Michael Moritz, Caroline Riely, Lainie Ross, James Scott, Lynne Wagoner, Lucile Wrenshall. Consensus Committee Organizers: Patricia Adams, Ginny Bumgardner, Richard Fine, Simin Goral, Olivia Martinez, Nina Tolkoff-Rubin, Martha Pavlakis and Velma Scantlebury. . Reproduction and Transplantation: Report on the AST Consensus Conference on Reproductive Issues and Transplantation. American Journal of Transplantation. 2005; 5(7):1592-1599.
  59. Avihingsanon Y, Ma N, Pavlakis M, Chon WJ, Uknis ME, Monaco AP, Ferran C, Stillman I, Schachter AD, Mottley C, Zheng XX, Strom TB. On the intraoperative molecular status of renal allografts after vascular reperfusion and clinical outcomes. J Am Soc Nephrol. 2005 Jun; 16(6):1542-8.
    View in: PubMed
  60. Pavlakis M, Haririan A, Klassen D. BK Virus Infection after Non-Renal Transplantation. Polyomavirus and Human Diseases (Ahsan, ed.). 2005.
  61. Delmonico FL, Morrissey PE, Lipkowitz GS, Stoff JS, Himmelfarb J, Harmon W, Pavlakis M, Mah H, Goguen J, Luskin R, Milford E, Basadonna G, Chobanian M, Bouthot B, Lorber M, Rohrer RJ. Donor kidney exchanges. Am J Transplant. 2004 Oct; 4(10):1628-34.
    View in: PubMed
  62. Nadey Hakims, Kathleen Lake, Phillip O’Connell, Martha Pavlakis. Getting a New Pancreas: Facts about Pancreas Transplantation. 2003.
  63. Tracy Daveyduke Kathleen Lake Ingrid Larsen Sherry Newitt Martha Pavlakis James Shapiro Lana Toth. Getting New Islet Cells; Facts About Clinical Islet Transplants. 2003.
  64. Sakoulas G, Koralnik I, Shaffer D, Pavlakis M. Fatal cardiovascular Collapse Due to BK Virus Infection of Capillary Endothelial Cells in a Renal Transplant Recipient: A Novel Clinical Syndrome. Graft. 2002; 5:S104-S110.
  65. Avihingsanon Y, Ma N, Csizmadia E, Wang C, Pavlakis M, Giraldo M, Strom TB, Soares MP, Ferran C. Expression of protective genes in human renal allografts: a regulatory response to injury associated with graft rejection. Transplantation. 2002 Apr 15; 73(7):1079-85.
    View in: PubMed
  66. Jani A, Polhemus C, Corrigan G, Kwon O, Myers BD, Pavlakis M. Determinants of hypofiltration during acute renal allograft rejection. J Am Soc Nephrol. 2002 Mar; 13(3):773-8.
    View in: PubMed
  67. Strehlau J, Schachter AD, Pavlakis M, Singh A, Tejani A, Strom TB. Activated intrarenal transcription of CTL-effectors and TGF-beta1 in children with focal segmental glomerulosclerosis. Kidney Int. 2002 Jan; 61(1):90-5.
    View in: PubMed
  68. Zeevi A, Pavlakis M, Spichty K, Chang S, Iacono A, Dauber J, Burckart G, McCurry K, Keenan R, Grgurich W, Griffith B. Prediction of rejection in lung transplantation. Transplant Proc. 2001 Feb-Mar; 33(1-2):291-2.
    View in: PubMed
  69. Sarwal MM, Jani A, Chang S, Huie P, Wang Z, Salvatierra O, Clayberger C, Sibley R, Krensky AM, Pavlakis M. Granulysin expression is a marker for acute rejection and steroid resistance in human renal transplantation. Hum Immunol. 2001 Jan; 62(1):21-31.
    View in: PubMed
  70. Rubin RH, Kemmerly SA, Conti D, Doran M, Murray BM, Neylan JF, Pappas C, Pitts D, Avery R, Pavlakis M, Del Busto R, DeNofrio D, Blumberg EA, Schoenfeld DA, Donohue T, Fisher SA, Fishman JA. Prevention of primary cytomegalovirus disease in organ transplant recipients with oral ganciclovir or oral acyclovir prophylaxis. Transpl Infect Dis. 2000 Sep; 2(3):112-7.
    View in: PubMed
  71. Soccal PM, Jani A, Chang S, Leonard CT, Pavlakis M, Doyle RL. Inducible nitric oxide synthase transcription in human lung transplantation. Transplantation. 2000 Jul 27; 70(2):384-5.
    View in: PubMed
  72. Soccal PM, Doyle RL, Jani A, Chang S, Akindipe OA, Poirier C, Pavlakis M. Quantification of cytotoxic T-cell gene transcripts in human lung transplantation. Transplantation. 2000 May 15; 69(9):1923-7.
    View in: PubMed
  73. Pavlakis M, Krensky A. . Immunologic Principles of Transplantation. Principles of Nephrology. Johnson R, Freehaly J, editors. 1999; 84.1-12.
  74. Strehlau J, Maslinski W, Chae D, Pavlakis M, Ehrich JH, Strom TB. Adjusting immunosuppression to the identification of T-cell activating mediators in rejecting transplants: a novel approach to rejection diagnosis and treatment. Transplant Proc. 1998 Aug; 30(5):2389-91.
    View in: PubMed
  75. Lee CM, Scandling JD, Pavlakis M, Markezich AJ, Dafoe DC, Alfrey EJ. A review of the kidneys that nobody wanted: determinants of optimal outcome. Transplantation. 1998 Jan 27; 65(2):213-9.
    View in: PubMed
  76. Jani A, Pavlakis M. After kidney transplantation: options for tailoring immunosuppression. ;. Nephrology Rounds. 1998; 2:1-7.
  77. Alfrey EJ, Lee CM, Scandling JD, Pavlakis M, Markezich AJ, Dafoe DC. When should expanded criteria donor kidneys be used for single versus dual kidney transplants? Transplantation. 1997 Oct 27; 64(8):1142-6.
    View in: PubMed
  78. Strehlau J, Pavlakis M, Lipman M, Shapiro M, Vasconcellos L, Harmon W, Strom TB. Quantitative detection of immune activation transcripts as a diagnostic tool in kidney transplantation. Proc Natl Acad Sci U S A. 1997 Jan 21; 94(2):695-700.
    View in: PubMed
  79. Desai DM, Scandling JD, Alfrey EJ, Pavlakis M, Salvatierra O, Conley SB, Tanney DC, Dafoe DC. Kidney and kidney/pancreas transplantation at Stanford University Medical Center. Clin Transpl. 1997; 135-47.
    View in: PubMed
  80. Desai D, Scandling J, Alfrey E, Pavlakis M, Salvatierra O, Conley S, Tanney D, Dafoe D. Kidney and Kidney/Pancreas Transplantation at Stanford University Medical Center. Clinical Transplants Editors: Cecka J and Terasaki P. 1997.
  81. Pavlakis M, Strehlau J, Lipman M, Shapiro M, Maslinski W, Strom TB. Intragraft IL-15 transcripts are increased in human renal allograft rejection. Transplantation. 1996 Aug 27; 62(4):543-5.
    View in: PubMed
  82. Pavlakis M, Strehlau J, Lipman M, Strom TB. Use of intragraft gene expression in the diagnosis of kidney allograft rejection. Transplant Proc. 1996 Aug; 28(4):2019-21.
    View in: PubMed
  83. Strehlau J, Pavlakis M, Lipman M, Maslinski W, Shapiro M, Strom TB. The intragraft gene activation of markers reflecting T-cell-activation and -cytotoxicity analyzed by quantitative RT-PCR in renal transplantation. Clin Nephrol. 1996 Jul; 46(1):30-3.
    View in: PubMed
  84. Barth C, Pavlakis M, Lavery P, Strom TB, Loertscher R. Restricted TCR V beta repertoire in the human mixed lymphocyte reaction is determined by the TCR on the responder cell and not by the stimulating antigen on the stimulator cell. Transplantation. 1996 Jan 15; 61(1):133-9.
    View in: PubMed
  85. Pavlakis M, Lipman M, Strom TB. Intragraft expression of T-cell activation genes in human renal allograft rejection. Kidney Int Suppl. 1996 Jan; 53:S7-12.
    View in: PubMed
  86. Pavlakis M, Lipman M, Strom TB. . Intragraft gene expression in human renal allograft rejection. Kidney Int. 1996; 53:S7-12.
  87. Pavlakis M, Strehlau J, Lipman M, Strom TB . The use of intragraft gene expression in the diagnosis of kidney allograft rejection. Transplant Proceedings. 1996; 28 (4 ):2019-21.
  88. Pavlakis M, Lipman ML, Strom TB. Intragraft T cell receptor transcript expression in human renal allografts. J Am Soc Nephrol. 1995 Aug; 6(2):281-5.
    View in: PubMed
  89. Clayberger C, DeKruyff RH, Fay R, Pavlakis M, Cantor H. Immunoregulation of T-dependent responses by a cloned dendritic cell. J Immunol. 1984 Sep; 133(3):1174-8.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact Human Resources at faculty_serviceshms.harvard.edu.
Pavlakis's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
See all (316) concept(s)
_
Co-Authors
See all (30) people
_
Similar People
See all (60) people
_
Same Department
Search Department
Physical Neighbors
_